摘要 |
<p>Oral antidepressant formulation comprising an effective antidepressant amount of one or more selective serotonin reuptake inhibitors, and an effective amount of at least a compound selected from the group consisting of acetylsalicylic acid, derivatives of acetylsalicylic acid, heparin, heparin like compounds, and mixtures thereof, for reducing the onset of action of the selective serotonin reuptake inhibitor(s).</p> |